Top movers | SPLK surges 20% on CSCO deal; FDX beats EPS; BGNE got downgraded
1. $Splunk(SPLK)$ surges 20% on $Cisco(CSCO)$’s $28 billion all-cash deal
Cisco is acquiring cybersecurity firm Splunk for $157 per share in a $28 billion all-cash deal. Splunk rises 20% before the bell.
The acquisition is part of Cisco's ongoing expansion in the cybersecurity sector. Cisco plans to finance the deal with cash and debt, expecting it to be profitable within the first year and accretive to earnings per share within the second year.
The deal is set to close in the third quarter of 2024.
2. $BeiGene(BGNE)$ fell 7.67% with medical peers and got downgrade by BAC analyst
BeiGene, a biotechnology company, has seen a change in its stock assessment by Bank of America Securities analyst David Li. He previously had a HOLD rating on BeiGene with a price target of $225.58, suggesting potential upside.
However, in his latest update, Li has adjusted the rating to Neutral and lowered the price target to $212. This change indicates a less optimistic outlook for BeiGene's stock compared to his previous assessment.
3. $FedEx(FDX)$ surges 4.25% on lifted guidance and EPS beats
FedEx (FDX) experienced a surge in its stock price after reporting strong Q1 2024 earnings, with adjusted earnings per share reaching $4.55, up by 32.3% after four quarters of declines.
The results were well above FactSet analyst estimates of $3.71 per share. Revenue declined 6.5% to $21.7 billion, just shy of forecasts of $21.74 billion.
FedEx adjusted its fiscal 2024 guidance to flat year-over-year revenue, with adjusted earnings projected between $17 and $18.50 per share.
The company plans to invest $5.7 billion in efficiency improvements and expects $1.8 billion in permanent annual cost reductions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Great ariticle, would you like to share it?
Great ariticle, would you like to share it?